Autocrine transforming growth factor β suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells

Cell Growth and Differentiation

Volumn 12, Issue 2, 2001, Pages 119-127

  Yang, H ^a   Kyo, S ^a   Takatura, M ^a   Sun, L ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOCRINE EFFECT; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; COLON CARCINOMA; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

AUTOCRINE COMMUNICATION; BREAST NEOPLASMS; COLONIC NEOPLASMS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; HUMANS; RNA; RNA, MESSENGER; TELOMERASE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035126895     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Structure and function of telomeres
2. Telomerase activity in human germline and embryonic tissues and cells
3. Telomerase activity in human cancer
4. Specific association of human telomerase activity with immortal cells and cancer
5. Telomerase, cell immortality, and cancer
6. The RNA component of human telomerase
7. Telomerase catalytic subunit homologs from fission yeast and human
8. A mammalian telomerase-associated protein
9. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization
10. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
11. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
12. Extension of life-span by introduction of telomerase into normal human cells
13. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells
14. Up-regulation of telomerase activity in human lymphocytes
15. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes
16. Telomerase activity in human endometrium
17. Telomerase assays in the diagnosis and prognosis of cancer
18. Regulation of telomerase activity in immortal cell lines
19. Telomerase activity, cell proliferation, and cancer
20. TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
21. TGF-β signal transduction
22. Specificity, diversity, and regulation in TGF-β superfamily signaling
23. Serine/threonine kinase receptors: Mediators of transforming growth factor β family signals
24. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells
25. Transforming growth factor β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice
26. Transforming growth factor β1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation
27. Expression of a dominant negative type II TGF-β receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development
28. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor β receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene
29. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability
30. Repression of autocrine transforming growth factor β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties
31. Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells
32. Expression of transforming growth factor β (TGFβ) type III receptor restores autocrine TGF β1 activity in human breast cancer MCF-7 cells
33. Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells
34. A kinase-defective transforming growth factor-β receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells
35. TGF β signals through a heteromeric protein kinase receptor complex
36. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
37. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer
38. PCR MIMICS: Competitive DNA fragments for use as internal standards in quantitative PCR
39. The transforming growth factor-βs
40. Tumor suppressor activity of the TGF-β pathway in human cancers
41. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
42. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT
43. Differentiation of immortal cells inhibits telomerase activity
44. Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc
45. Cell cycle-dependent modulation of telomerase activity in tumor cells
46. Lack of cell cycle regulation of telomerase activity in human cells
47. TGF-β1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector
48. Myc activates telomerase
49. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA
50. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β
51. Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells
52. The human telomerase catalytic subunit hTERT: Organization of the gene and characterization of the promoter
53. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene
54. Rapid, small-scale RNA isolation from tissue culture cells
55. Competitive PCR
56. Molecular characterization of the murine Ahr gene. Organization, promoter analysis, and chromosomal assignment
57. Comparing simple linear regression equations